4 suspended. 4 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Suspended 4 |
| Phase 1 | 3 | Suspended 3 |
Follow Lymphoma, Large B-Cell, Diffuse: new trials by email Literature Review of Lymphoma, Large B-Cell, Diffuse trials Research Report on Lymphoma, Large B-Cell, Diffuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma Vevoctadekin, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 1 / Phase 2 | Suspended | Fred Hutchinson Cancer Center | 33 | 2025-12-27 | 2026-09-11 |
| A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma Brincidofovir - Relapsed or Refractory Lymphoma Including ENKL | Phase 1 / Phase 2 | Suspended | SymBio Pharmaceuticals | 43 | 2025-06-09 | 2026-02-05 |
| Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL E7777, Fludarabine, Cyclophosphamide - DLBCL, Diffuse Large B Cell Lymphoma | Phase 1 / Phase 2 | Suspended | Masonic Cancer Center, University of Minnesota | 30 | 2021-06-09 | 2026-01-15 |
| Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma Rituximab, Zanubrutinib, Cyclophosphamide - Diffuse Large B Cell Lymphoma, CD79A Gene Mutation | Phase 2 | Suspended | Henan Cancer Hospital | 59 | 2020-12-25 | 2025-04-25 |
Congenital Abnormalities (1) · Epstein-Barr Virus Infections (1) · Immunoblastic Lymphadenopathy (1) · Leukemia-Lymphoma, Adult T-Cell (1) · Lymphoma (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, T-Cell (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoma, B-Cell (4) · Lymphoma, Non-Hodgkin (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Lymphoma (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · DNA Virus Infections (1) · Disease Attributes (1) · Hematologic Diseases (1) · Herpesviridae Infections (1)
Cyclophosphamide (2) · Biopsy (1) · E7777 fusion protein (1) · Epirubicin (1) · Leukapheresis (1) · Magnetic Resonance Spectroscopy (1) · Phantoms, Imaging (1) · Prednisone (1) · Rituximab (1) · Spinal Puncture (1) · Vincristine (1) · X-Rays (1) · axicabtagene ciloleucel (1) · brincidofovir (1) · fludarabine (1)
Fred Hutchinson Cancer Center (1) · Henan Cancer Hospital (1) · Masonic Cancer Center, University of Minnesota (1) · SymBio Pharmaceuticals (1)
China (2) · United States (2) · Japan (1) · Singapore (1)
Alexandre V. Hirayama, MD (1) · Veronika Bachanova, MD (1) · Yanyan Liu, M.D. Ph.D (1) · Zhihua Yao, M.D. Ph.D (1)